Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Brain+ | BRAINP | Apr 19, 2024 | 0.12 | -3.77 |
Brd. Klee B | KLEEB | Apr 19, 2024 | 4 380.00 | 0.00 |
Brdr. A & O Johansen Pref B | AOJB | Apr 19, 2024 | 72.80 | +0.97 |
Brøndbyernes IF Fodbold | BIF | Apr 19, 2024 | 0.71 | +3.18 |
Carlsberg A | CARLA | Apr 19, 2024 | 1 120.00 | -0.44 |
Carlsberg B | CARLB | Apr 19, 2024 | 927.60 | +3.16 |
cBrain | CBRAIN | Apr 19, 2024 | 306.50 | -1.92 |
Cemat | CEMAT | Apr 19, 2024 | 0.87 | -3.54 |
Cessatech A/S | CEASES | Apr 19, 2024 | 6.06 | 0.00 |
ChemoMetec | CHEMM | Apr 19, 2024 | 285.20 | -0.83 |
Coloplast B | COLOB | Apr 19, 2024 | 906.00 | +1.09 |
Columbus | COLUM | Apr 19, 2024 | 9.38 | +0.43 |
Conferize | CONFRZ | Apr 19, 2024 | 0.02 | 0.00 |
Copenhagen Capital | CPHCAPST | Apr 19, 2024 | 5.20 | -0.95 |
Copenhagen Capital 40 pct Pref 2032 | CPHCAPPREF32 | Apr 19, 2024 | 8.10 | 0.00 |
CS Medica | CSMED | Apr 19, 2024 | 3.97 | -0.25 |
D/S Norden | DNORD | Apr 19, 2024 | 288.20 | +0.77 |
DanCann Pharma A/S | DANCE | Apr 19, 2024 | 0.03 | 0.00 |
Danish Aerospace Company | DAC | Apr 19, 2024 | 3.14 | -1.88 |
Danske Andelskassers Bank | DAB | Apr 19, 2024 | 12.40 | +7.36 |
Danske Bank | DANSKE | Apr 19, 2024 | 202.90 | +0.05 |
Dantax | DANT | Apr 19, 2024 | 392.00 | 0.00 |
Dataproces Group | DATA | Apr 19, 2024 | 2.70 | -4.26 |
DecideAct | ACT | Apr 19, 2024 | 3.08 | 0.00 |
Demant | DEMANT | Apr 19, 2024 | 315.60 | +1.48 |
DFDS | DFDS | Apr 19, 2024 | 206.20 | 0.00 |
Djurslands Bank | DJUR | Apr 19, 2024 | 525.00 | +0.96 |
Donkey Republic | DONKEY | Apr 19, 2024 | 6.50 | -3.70 |
DSV | DSV | Apr 19, 2024 | 1 070.00 | -0.37 |
EAC Invest | EAC | Apr 19, 2024 | 10 700.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.